Quantcast

Pfizer, BioNTech get FDA’s support for potential first emergency use authorization for COVID-19 vaccine in the U.S.

Pfizer and BioNTech said that the FDA is expected to make a decision on Emergency Use Authorization in the coming days after giving a positive vote based on totality of scientific evidence presented by the companies, including Phase 3 efficacy and safety data, which would make BNT162b2 the first COVID-19 vaccine available in the U.S.

Read more